Canada· CA-DIN-02517760
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI
A clotrimazole product containing fluconazole + clotrimazole, registered in Canada by TARO PHARMACEUTICALS INC. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Clotrimazole is registered in 13 of 19 countries.
Countries holding a registration under ATC G01AF02 (clotrimazole), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Clotrimazole · ATC G01AF02
13 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- FLUCONAZOLE + CLOTRIMAZOLE
- Manufacturer
- TARO PHARMACEUTICALS INC
- Country
- Canada (CA)
- ATC code
- G01AF02
- ATC class
- Clotrimazole
- Defined daily dose
- 0.1 g, V
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
592 interactions on record for clotrimazole.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clotrimazole · interactions on record
592 records
- 35 severe
- 240 moderate
- 28 minor
- 289 info
Most severe, free to view
- EliglustatA16AX10severe
- LonafarnibA16AX20severe
- AmiodaroneC01BD01severe
- IvabradineC01EB17severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G01AF02
Clotrimazole, as other registers publish it.
- United KingdomAbtrim 500mg pessariesAshbourne Pharmaceuticals Ltd
- GermanyAntifungol Hexal 3 Vaginalcreme Hexal AgHexal Ag
- CzechiaCANDIBENEratiopharm GmbH, Ulm
- CzechiaCANDIBENEratiopharm GmbH, Ulm
- United KingdomCandiden 500mg pessariesAkita Pharmaceuticals Ltd
- FinlandCanestenOrifarm Oy
- FinlandCanestenParanova Oy
- FinlandCanestenBayer Oy
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Canesten Thrush Duo Oral Capsule & External Cream
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7bc7947b-1e09-43af-9454-a68f68b14c84 GET /v1/drugs/7bc7947b-1e09-43af-9454-a68f68b14c84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02517760",
"form": "CAPSULE",
"class": "Human",
"routes": [
"TOPICAL",
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G01AF02",
"schedule": [
"OTC"
],
"drug_code": "100712",
"strengths": [
"150 MG",
"2 %"
],
"ahfs_class": null,
"substances": [
"FLUCONAZOLE",
"CLOTRIMAZOLE"
],
"product_categorization": null
}See everything about clotrimazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.